Rebecca Guntern

Rebecca Guntern is the Chief Commercial Officer of Sandoz, a Swiss pharmaceutical company renowned for its focus on generics and biosimilars. In her role, she emphasizes the critical need to maintain the production of essential medications within Europe, particularly in light of recent supply chain vulnerabilities exposed by the COVID-19 pandemic. Guntern advocates for strategic measures to enhance the pharmaceutical supply chain in Europe, addressing challenges such as over-reliance on Asian suppliers and the complexities of producing generics. Her insights reflect a commitment to ensuring that Europe remains self-sufficient in the manufacturing of vital medications.